CryoLife Inc (CRY) - Product Pipeline Analysis, 2018 Update
- GDME300PD
- Pages: 37
- August 2018
- Region : North America
- GlobalData
- Equity Research Report

- Details
- Table Of Content
- Licence Rights
- Section Purchase
- Products and Companies
Details
Summary
CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company's portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide diffuser, bovine pericardium, and mitral chordal repair products. CryoLife serves physicians, cardiac surgeons, hospitals, and medical institutions. The company has manufacturing facilities in Texas and Georgia in the US. The company distributes its products through its subsidiaries and independent distributors in the Middle East, and Africa, European Economic Area, Asia-Pacific and the Americas. CryoLife is headquartered in Atlanta, Georgia, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CryoLife Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table Of Content
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
CryoLife Inc Company Overview 4
CryoLife Inc Company Snapshot 4
CryoLife Inc Pipeline Products and Ongoing Clinical Trials Overview 4
CryoLife Inc-Pipeline Analysis Overview 7
Business Description 7
CryoLife Inc-Key Facts 7
CryoLife Inc-Major Products and Services 8
CryoLife Inc Pipeline Products by Development Stage 10
CryoLife Inc Ongoing Clinical Trials by Trial Status 12
CryoLife Inc Pipeline Products Overview 13
Biodisc Nucleus Pulposus Replacement 13
Biodisc Nucleus Pulposus Replacement Product Overview 13
BioGlue Surgical Adhesive 14
BioGlue Surgical Adhesive Product Overview 14
BioGlue Surgical Adhesive-Adhesion And Hemostasis 15
BioGlue Surgical Adhesive-Adhesion And Hemostasis Product Overview 15
BioGlue Surgical Adhesive-Adhesion And Hemostasis Clinical Trial 16
CryoValve SGAV 17
CryoValve SGAV Product Overview 17
PerClot 18
PerClot Product Overview 18
PerClot Clinical Trial 19
Synergraft Xenograft Heart Valve 20
Synergraft Xenograft Heart Valve Product Overview 20
Synergraft Xenograft Vascular Graft 21
Synergraft Xenograft Vascular Graft Product Overview 21
CryoLife Inc-Key Competitors 22
CryoLife Inc-Key Employees 23
CryoLife Inc-Key Employee Biographies 24
CryoLife Inc-Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
CryoLife Inc, Recent Developments 27
Jun 19, 2018: CryoLife Appoints Marna Borgstrom As Board Director 27
Jun 11, 2018: CryoLife Announces Peer Review Publication of On-X Aortic Heart Valve PROACT Study 27
May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results 28
Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results 29
Jan 29, 2018: Five devices for pediatrics get help in advancing to market 29
Nov 06, 2017: CryoLife Announces Enrollment of First Patients in BioGlue Clinical Trial in China 30
Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results 31
Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors 32
Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 32
Apr 27, 2017: CryoLife Announces On-X Aortic Heart Valve PROACT Study Results to be Presented at American Association for Thoracic Surgery Centennial Meeting 33
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37
List Of Figure
List of Figures
CryoLife Inc Pipeline Products by Equipment Type 5
CryoLife Inc Pipeline Products by Development Stage 10
CryoLife Inc Ongoing Clinical Trials by Trial Status 12
List Of Table
List of Tables
CryoLife Inc Pipeline Products and Ongoing Clinical Trials Overview 4
CryoLife Inc Pipeline Products by Equipment Type 5
CryoLife Inc Pipeline Products by Indication 6
CryoLife Inc Ongoing Clinical Trials by Trial Status 6
CryoLife Inc, Key Facts 7
CryoLife Inc, Major Products and Services 8
CryoLife Inc Number of Pipeline Products by Development Stage 10
CryoLife Inc Pipeline Products Summary by Development Stage 11
CryoLife Inc Ongoing Clinical Trials by Trial Status 12
CryoLife Inc Ongoing Clinical Trials Summary 12
Biodisc Nucleus Pulposus Replacement-Product Status 13
Biodisc Nucleus Pulposus Replacement-Product Description 13
BioGlue Surgical Adhesive-Product Status 14
BioGlue Surgical Adhesive-Product Description 14
BioGlue Surgical Adhesive-Adhesion And Hemostasis-Product Status 15
BioGlue Surgical Adhesive-Adhesion And Hemostasis-Product Description 15
BioGlue Surgical Adhesive-Adhesion And Hemostasis-A Prospective, Multicenter Study of BioGlue in the Treatment of Chinese Patients with Acute Type A Aortic Dissections 16
CryoValve SGAV-Product Status 17
CryoValve SGAV-Product Description 17
PerClot-Product Status 18
PerClot-Product Description 18
PerClot-Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot Polysaccharide Hemostatic System 19
Synergraft Xenograft Heart Valve-Product Status 20
Synergraft Xenograft Heart Valve-Product Description 20
Synergraft Xenograft Vascular Graft-Product Status 21
Synergraft Xenograft Vascular Graft-Product Description 21
CryoLife Inc, Key Employees 23
CryoLife Inc, Key Employee Biographies 24
CryoLife Inc, Subsidiaries 25
Glossary 36
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
Products and Companies
Products
CryoLife Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
W. L. Gore & Associates Inc
St. Jude Medical LLC
Pfizer Inc
Medtronic Plc
MAQUET, Inc.
Ethicon US LLC
Edwards Lifesciences Corp
C. R. Bard Inc
Summary
CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company's portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide diffuser, bovine pericardium, and mitral chordal repair products. CryoLife serves physicians, cardiac surgeons, hospitals, and medical institutions. The company has manufacturing facilities in Texas and Georgia in the US. The company distributes its products through its subsidiaries and independent distributors in the Middle East, and Africa, European Economic Area, Asia-Pacific and the Americas. CryoLife is headquartered in Atlanta, Georgia, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CryoLife Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
CryoLife Inc Company Overview 4
CryoLife Inc Company Snapshot 4
CryoLife Inc Pipeline Products and Ongoing Clinical Trials Overview 4
CryoLife Inc-Pipeline Analysis Overview 7
Business Description 7
CryoLife Inc-Key Facts 7
CryoLife Inc-Major Products and Services 8
CryoLife Inc Pipeline Products by Development Stage 10
CryoLife Inc Ongoing Clinical Trials by Trial Status 12
CryoLife Inc Pipeline Products Overview 13
Biodisc Nucleus Pulposus Replacement 13
Biodisc Nucleus Pulposus Replacement Product Overview 13
BioGlue Surgical Adhesive 14
BioGlue Surgical Adhesive Product Overview 14
BioGlue Surgical Adhesive-Adhesion And Hemostasis 15
BioGlue Surgical Adhesive-Adhesion And Hemostasis Product Overview 15
BioGlue Surgical Adhesive-Adhesion And Hemostasis Clinical Trial 16
CryoValve SGAV 17
CryoValve SGAV Product Overview 17
PerClot 18
PerClot Product Overview 18
PerClot Clinical Trial 19
Synergraft Xenograft Heart Valve 20
Synergraft Xenograft Heart Valve Product Overview 20
Synergraft Xenograft Vascular Graft 21
Synergraft Xenograft Vascular Graft Product Overview 21
CryoLife Inc-Key Competitors 22
CryoLife Inc-Key Employees 23
CryoLife Inc-Key Employee Biographies 24
CryoLife Inc-Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
CryoLife Inc, Recent Developments 27
Jun 19, 2018: CryoLife Appoints Marna Borgstrom As Board Director 27
Jun 11, 2018: CryoLife Announces Peer Review Publication of On-X Aortic Heart Valve PROACT Study 27
May 02, 2018: CryoLife Announces First Quarter 2018 Financial Results 28
Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results 29
Jan 29, 2018: Five devices for pediatrics get help in advancing to market 29
Nov 06, 2017: CryoLife Announces Enrollment of First Patients in BioGlue Clinical Trial in China 30
Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results 31
Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors 32
Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 32
Apr 27, 2017: CryoLife Announces On-X Aortic Heart Valve PROACT Study Results to be Presented at American Association for Thoracic Surgery Centennial Meeting 33
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37
List Of Figure
List of Figures
CryoLife Inc Pipeline Products by Equipment Type 5
CryoLife Inc Pipeline Products by Development Stage 10
CryoLife Inc Ongoing Clinical Trials by Trial Status 12
List Of Table
List of Tables
CryoLife Inc Pipeline Products and Ongoing Clinical Trials Overview 4
CryoLife Inc Pipeline Products by Equipment Type 5
CryoLife Inc Pipeline Products by Indication 6
CryoLife Inc Ongoing Clinical Trials by Trial Status 6
CryoLife Inc, Key Facts 7
CryoLife Inc, Major Products and Services 8
CryoLife Inc Number of Pipeline Products by Development Stage 10
CryoLife Inc Pipeline Products Summary by Development Stage 11
CryoLife Inc Ongoing Clinical Trials by Trial Status 12
CryoLife Inc Ongoing Clinical Trials Summary 12
Biodisc Nucleus Pulposus Replacement-Product Status 13
Biodisc Nucleus Pulposus Replacement-Product Description 13
BioGlue Surgical Adhesive-Product Status 14
BioGlue Surgical Adhesive-Product Description 14
BioGlue Surgical Adhesive-Adhesion And Hemostasis-Product Status 15
BioGlue Surgical Adhesive-Adhesion And Hemostasis-Product Description 15
BioGlue Surgical Adhesive-Adhesion And Hemostasis-A Prospective, Multicenter Study of BioGlue in the Treatment of Chinese Patients with Acute Type A Aortic Dissections 16
CryoValve SGAV-Product Status 17
CryoValve SGAV-Product Description 17
PerClot-Product Status 18
PerClot-Product Description 18
PerClot-Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot Polysaccharide Hemostatic System 19
Synergraft Xenograft Heart Valve-Product Status 20
Synergraft Xenograft Heart Valve-Product Description 20
Synergraft Xenograft Vascular Graft-Product Status 21
Synergraft Xenograft Vascular Graft-Product Description 21
CryoLife Inc, Key Employees 23
CryoLife Inc, Key Employee Biographies 24
CryoLife Inc, Subsidiaries 25
Glossary 36
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Products
CryoLife Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
W. L. Gore & Associates Inc
St. Jude Medical LLC
Pfizer Inc
Medtronic Plc
MAQUET, Inc.
Ethicon US LLC
Edwards Lifesciences Corp
C. R. Bard Inc